285 related articles for article (PubMed ID: 37873584)
1. Genetically engineered bacteria: a new frontier in targeted drug delivery.
Fooladi S; Rabiee N; Iravani S
J Mater Chem B; 2023 Nov; 11(42):10072-10087. PubMed ID: 37873584
[TBL] [Abstract][Full Text] [Related]
2. Bacterial genome engineering and synthetic biology: combating pathogens.
Krishnamurthy M; Moore RT; Rajamani S; Panchal RG
BMC Microbiol; 2016 Nov; 16(1):258. PubMed ID: 27814687
[TBL] [Abstract][Full Text] [Related]
3. Recent Advances in Pharmaceutical Design: Unleashing the Potential of Novel Therapeutics.
Prajapati RN; Bhushan B; Singh K; Chopra H; Kumar S; Agrawal M; Pathak D; Chanchal DK; Laxmikant
Curr Pharm Biotechnol; 2024 Jan; ():. PubMed ID: 38288793
[TBL] [Abstract][Full Text] [Related]
4. Genetically engineered oncolytic bacteria as drug delivery systems for targeted cancer theranostics.
Chen Y; Liu X; Guo Y; Wang J; Zhang D; Mei Y; Shi J; Tan W; Zheng JH
Acta Biomater; 2021 Apr; 124():72-87. PubMed ID: 33561563
[TBL] [Abstract][Full Text] [Related]
5. Theranostic Nanoparticles for RNA-Based Cancer Treatment.
Revia RA; Stephen ZR; Zhang M
Acc Chem Res; 2019 Jun; 52(6):1496-1506. PubMed ID: 31135134
[TBL] [Abstract][Full Text] [Related]
6. Engineered CRISPR Systems for Next Generation Gene Therapies.
Pineda M; Moghadam F; Ebrahimkhani MR; Kiani S
ACS Synth Biol; 2017 Sep; 6(9):1614-1626. PubMed ID: 28558198
[TBL] [Abstract][Full Text] [Related]
7. Bacterially mediated drug delivery and therapeutics: Strategies and advancements.
Wu L; Bao F; Li L; Yin X; Hua Z
Adv Drug Deliv Rev; 2022 Aug; 187():114363. PubMed ID: 35649449
[TBL] [Abstract][Full Text] [Related]
8. Progress of engineered bacteria for tumour therapy.
Xia X; Zhang JW; Zhao B; Zhang M; Chen ZR; Zhang BF; Ji YL; Wang X; Xiong WM; Li JW; Lv QL
Int Immunopharmacol; 2024 May; 132():111935. PubMed ID: 38599096
[TBL] [Abstract][Full Text] [Related]
9. Biologics, theranostics, and personalized medicine in drug delivery systems.
Puccetti M; Pariano M; Schoubben A; Giovagnoli S; Ricci M
Pharmacol Res; 2024 Mar; 201():107086. PubMed ID: 38295917
[TBL] [Abstract][Full Text] [Related]
10. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
11. Bacteria and bacterial derivatives as drug carriers for cancer therapy.
Cao Z; Liu J
J Control Release; 2020 Oct; 326():396-407. PubMed ID: 32681947
[TBL] [Abstract][Full Text] [Related]
12. Advances in anti-tumor based on various anaerobic bacteria and their derivatives as drug vehicles.
Song D; Yang X; Chen Y; Hu P; Zhang Y; Zhang Y; Liang N; Xie J; Qiao L; Deng G; Chen F; Zhang J
Front Bioeng Biotechnol; 2023; 11():1286502. PubMed ID: 37854883
[TBL] [Abstract][Full Text] [Related]
13. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
14. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
15. Diabetology and Nanotechnology: A Compelling Combination.
Karwasra R; Sharma S; Sharma I; Shahid N; Umar T
Recent Pat Nanotechnol; 2023 Nov; ():. PubMed ID: 37937555
[TBL] [Abstract][Full Text] [Related]
16. Regulatory insights into nanomedicine and gene vaccine innovation: Safety assessment, challenges, and regulatory perspectives.
Souto EB; Blanco-Llamero C; Krambeck K; Kiran NS; Yashaswini C; Postwala H; Severino P; Priefer R; Prajapati BG; Maheshwari R
Acta Biomater; 2024 May; 180():1-17. PubMed ID: 38604468
[TBL] [Abstract][Full Text] [Related]
17. Nanosize drug delivery system.
Mukherjee B
Curr Pharm Biotechnol; 2013; 14(15):1221. PubMed ID: 25106648
[TBL] [Abstract][Full Text] [Related]
18. New approaches in extracellular vesicle engineering for improving the efficacy of anti-cancer therapies.
Jayasinghe MK; Tan M; Peng B; Yang Y; Sethi G; Pirisinu M; Le MTN
Semin Cancer Biol; 2021 Sep; 74():62-78. PubMed ID: 33609665
[TBL] [Abstract][Full Text] [Related]
19. Biodegradable Polymer-Based Drug-Delivery Systems for Ocular Diseases.
Tsung TH; Tsai YC; Lee HP; Chen YH; Lu DW
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629157
[TBL] [Abstract][Full Text] [Related]
20. Nano based drug delivery systems: recent developments and future prospects.
Patra JK; Das G; Fraceto LF; Campos EVR; Rodriguez-Torres MDP; Acosta-Torres LS; Diaz-Torres LA; Grillo R; Swamy MK; Sharma S; Habtemariam S; Shin HS
J Nanobiotechnology; 2018 Sep; 16(1):71. PubMed ID: 30231877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]